1-201062005-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000069.3(CACNA1S):​c.2992G>A​(p.Asp998Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000318 in 1,614,174 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D998E) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0016 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00018 ( 2 hom. )

Consequence

CACNA1S
NM_000069.3 missense

Scores

4
11
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 3.66

Publications

0 publications found
Variant links:
Genes affected
CACNA1S (HGNC:1397): (calcium voltage-gated channel subunit alpha1 S) This gene encodes one of the five subunits of the slowly inactivating L-type voltage-dependent calcium channel in skeletal muscle cells. Mutations in this gene have been associated with hypokalemic periodic paralysis, thyrotoxic periodic paralysis and malignant hyperthermia susceptibility. [provided by RefSeq, Jul 2008]
CACNA1S Gene-Disease associations (from GenCC):
  • congenital myopathy 18
    Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hypokalemic periodic paralysis, type 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • malignant hyperthermia, susceptibility to, 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
  • congenital myopathy
    Inheritance: SD, AR, AD Classification: STRONG Submitted by: Illumina, Genomics England PanelApp
  • hypokalemic periodic paralysis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.022487909).
BP6
Variant 1-201062005-C-T is Benign according to our data. Variant chr1-201062005-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 225282.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00164 (250/152318) while in subpopulation AFR AF = 0.0058 (241/41570). AF 95% confidence interval is 0.0052. There are 2 homozygotes in GnomAd4. There are 121 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000069.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1S
NM_000069.3
MANE Select
c.2992G>Ap.Asp998Asn
missense
Exon 24 of 44NP_000060.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1S
ENST00000362061.4
TSL:1 MANE Select
c.2992G>Ap.Asp998Asn
missense
Exon 24 of 44ENSP00000355192.3
CACNA1S
ENST00000367338.7
TSL:5
c.2992G>Ap.Asp998Asn
missense
Exon 24 of 43ENSP00000356307.3
CACNA1S
ENST00000681874.1
c.2932G>Ap.Asp978Asn
missense
Exon 23 of 43ENSP00000505162.1

Frequencies

GnomAD3 genomes
AF:
0.00164
AC:
249
AN:
152200
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00579
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000442
AC:
111
AN:
251354
AF XY:
0.000353
show subpopulations
Gnomad AFR exome
AF:
0.00591
Gnomad AMR exome
AF:
0.0000579
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000440
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000181
AC:
264
AN:
1461856
Hom.:
2
Cov.:
33
AF XY:
0.000175
AC XY:
127
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.00603
AC:
202
AN:
33480
American (AMR)
AF:
0.000157
AC:
7
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000209
AC:
18
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53404
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000117
AC:
13
AN:
1112004
Other (OTH)
AF:
0.000381
AC:
23
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
16
32
47
63
79
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00164
AC:
250
AN:
152318
Hom.:
2
Cov.:
33
AF XY:
0.00162
AC XY:
121
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00580
AC:
241
AN:
41570
American (AMR)
AF:
0.000261
AC:
4
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68018
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
12
25
37
50
62
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000612
Hom.:
0
Bravo
AF:
0.00180
ESP6500AA
AF:
0.00386
AC:
17
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000560
AC:
68
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hypokalemic periodic paralysis, type 1 (1)
-
1
-
Malignant hyperthermia of anesthesia (1)
-
-
1
Malignant hyperthermia, susceptibility to, 5 (1)
-
-
1
Malignant hyperthermia, susceptibility to, 5;C3714580:Hypokalemic periodic paralysis, type 1 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Uncertain
-0.060
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.73
D
Eigen
Uncertain
0.51
Eigen_PC
Uncertain
0.53
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.97
D
M_CAP
Uncertain
0.087
D
MetaRNN
Benign
0.022
T
MetaSVM
Pathogenic
0.85
D
MutationAssessor
Uncertain
2.8
M
PhyloP100
3.7
PrimateAI
Uncertain
0.59
T
PROVEAN
Pathogenic
-4.6
D
REVEL
Pathogenic
0.67
Sift
Uncertain
0.028
D
Sift4G
Uncertain
0.036
D
Polyphen
0.60
P
Vest4
0.39
MVP
0.94
MPC
0.34
ClinPred
0.11
T
GERP RS
5.2
Varity_R
0.70
gMVP
0.97
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116347156; hg19: chr1-201031133; COSMIC: COSV62942794; API